Ligand Pharmaceuticals
LGND
LGND
233 hedge funds and large institutions have $1.45B invested in Ligand Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 81 increasing their positions, 74 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
233
Holders Change
+12
Holders Change %
+5.43%
% of All Funds
3.39%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
41
Increased
81
Reduced
74
Closed
26
Calls
$6.3M
Puts
$665K
Net Calls
+$5.64M
Net Calls Change
+$521K
Top Buyers
Top Sellers
| 1 |
CCMLC
Cardinal Capital Management LLC (Connecticut)
Greenwich,
Connecticut
|
-$35.9M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$5.61M |
| 3 |
Man Group
London,
United Kingdom
|
-$5.02M |
| 4 |
Morgan Stanley
New York
|
-$4.85M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$4.69M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VI
251
Vestcor Inc
Fredericton,
New Brunswick, Canada
| – | -$95K | -1,293 | Closed |
|
|
SI
252
Stephens Inc
Little Rock,
Arkansas
| – | -$80K | -1,094 | Closed |
|
|
MLICM
253
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$65.6K | -897 | Closed |
|
|
A
254
AlphaQuest
New York
| – | -$19.4K | -266 | Closed |
|
|
SWM
255
Spire Wealth Management
Mclean,
Virginia
| – | -$7.31K | -100 | Closed |
|
256
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$5.78K | -79 | Closed |
|
|
AWM
257
Avior Wealth Management
Omaha,
Nebraska
| – | -$5.77K | -79 | Closed |
|
|
FSWA
258
Financial Synergies Wealth Advisors
Houston,
Texas
| – | -$951 | -13 | Closed |
|